Evaluation of the Analgesic Efficacy of an Ultrasound-guided Transperineal Pudendal Block in Outpatient Hemorrhoidal Surgery
Launched by GCS RAMSAY SANTÉ POUR L'ENSEIGNEMENT ET LA RECHERCHE · Jun 3, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two different ways to provide pain relief during and after outpatient surgery for hemorrhoids. Specifically, the researchers want to see which method is more effective at reducing pain right after the surgery. One group of patients will receive a nerve block using a technique called neurostimulation, while the other group will receive a nerve block guided by ultrasound. Both groups will be monitored for how much pain they feel in the recovery room before they receive any additional pain medication.
To participate in this study, you must be an adult who is scheduled for hemorrhoid surgery under general anesthesia and willing to give your consent to join. However, there are some people who cannot participate, such as those who have had hemorrhoid surgery before, have certain allergies, or are pregnant. If you qualify and decide to join, you can expect careful monitoring of your pain levels after the surgery to help determine which pain relief method works best. This study is not yet recruiting participants, but it aims to find better ways to manage pain for patients undergoing this common procedure.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult male or female patient
- • Patient who has signed informed consent to participate in the study
- • Patient scheduled for outpatient hemorrhoidal surgery under general anesthesia
- Exclusion Criteria:
- • History of hemorrhoidal surgery
- • Allergy or contraindication to any of the medications used in the study
- • Patient undergoing surgery under spinal anesthesia
- • History of chronic pain requiring opioid use, unrelated to hemorrhoids
- • Mental impairment or any other condition that could hinder understanding or strict adherence to the protocol
- • Patient not affiliated with the French national health insurance system
- • Patient under legal protection (e.g., guardianship, trusteeship, or court protection)
- • Pregnant woman or woman at risk of being pregnant (i.e., of childbearing age without effective contraception and without an HCG test)
- • Patient already enrolled in another therapeutic clinical trial or within the exclusion period of another clinical trial
About Gcs Ramsay Santé Pour L'enseignement Et La Recherche
GCS Ramsay Santé pour l'Enseignement et la Recherche is a leading clinical trial sponsor dedicated to advancing healthcare through innovative research and education. As a collaborative group, it unites academic institutions and healthcare professionals to facilitate high-quality clinical trials that enhance patient care and contribute to medical knowledge. With a focus on rigorous scientific standards and ethical practices, GCS Ramsay Santé plays a crucial role in the development of new therapies and treatment protocols, ensuring that cutting-edge research translates into tangible benefits for patients and the broader community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Quincy Sous Sénart, , France
Patients applied
Trial Officials
Thomas GIRAL, MD
Principal Investigator
Hôpital privé Claude Galien
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported